UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 134

Sortiert nach

Lapatinib: A dual inhibitor of human epidermal growth factor receptor tyrosine kinases

Clinical therapeutics, 2008-08, Vol.30 (8), p.1426-1447

2008

Volltextzugriff (PDF)

Novel cytotoxic agents: Epothilones

American journal of health-system pharmacy, 2008-05, Vol.65 (10 Supplement 3), p.S10-S15

Goodin, Susan

2008

Volltextzugriff (PDF)

Mechanistic Study of Inhibitory Effects of Metformin and Atorvastatin in Combination on Prostate Cancer Cells in Vitro and in Vivo

Biological and Pharmaceutical Bulletin, 2017/08/01, Vol.40(8), pp.1247-1254

2017

Volltextzugriff (PDF)

Combination of α-Tomatine and Curcumin Inhibits Growth and Induces Apoptosis in Human Prostate Cancer Cells

PloS one, 2015-12, Vol.10 (12), p.e0144293-e0144293

2015

Volltextzugriff (PDF)

Epothilones: Mechanism of Action and Biologic Activity

Journal of clinical oncology, 2004-05, Vol.22 (10), p.2015-2025

2004

Volltextzugriff (PDF)

Oral chemotherapeutic agents: Understanding mechanisms of action and drug interactions

American journal of health-system pharmacy, 2007-05, Vol.64 (9 Supplement 5), p.S15-S24

Goodin, Susan

2007

Volltextzugriff (PDF)

Development of monoclonal antibodies for the treatment of colorectal cancer

American journal of health-system pharmacy, 2008-06, Vol.65 (11 Supplement 4), p.S3-S7

Goodin, Susan

2008

Volltextzugriff (PDF)

Inhibitory effect of roburic acid in combination with docetaxel on human prostate cancer cells

Journal of enzyme inhibition and medicinal chemistry, 2022-12, Vol.37 (1), p.542-553

2022

Volltextzugriff (PDF)

Eriocitrin in combination with resveratrol ameliorates LPS-induced inflammation in RAW264.7 cells and relieves TPA-induced mouse ear edema

Journal of functional foods, 2019-05, Vol.56, p.321-332

2019

Volltextzugriff (PDF)

Combination of diethyldithiocarbamate with 12-O-tetradecanoyl phorbol-13-acetate inhibits the growth of human myeloid leukemia HL-60 cells in vitro and in xenograft model

Bioscience, biotechnology, and biochemistry, 2020-10, Vol.84 (10), p.2069-2076

2020

Volltextzugriff (PDF)

Pharmacists’ critical role in cancer clinical trials

American journal of health-system pharmacy, 2018-05, Vol.75 (10), p.592-593

Goodin, Susan

2018

Volltextzugriff (PDF)

Synergistic inhibitory effect of α-humulene and sclareol on human pancreatic cancer cells

Journal of functional foods, 2022-02, Vol.89, p.104958, Article 104958

2022

Volltextzugriff (PDF)

Essential Oils from Zingiber striolatum Diels Attenuate Inflammatory Response and Oxidative Stress through Regulation of MAPK and NF-κB Signaling Pathways

Antioxidants, 2021-12, Vol.10 (12), p.2019

2021

Volltextzugriff (PDF)

Pharmacokinetics of Cetuximab After Administration of Escalating Single Dosing and Weekly Fixed Dosing in Patients with Solid Tumors

Clinical cancer research, 2006-11, Vol.12 (21), p.6517-6522

2006

Volltextzugriff (PDF)

Potent inhibitory effect of terpenoids from Acanthopanax trifoliatus on growth of PC-3 prostate cancer cells in vitro and in vivo is associated with suppression of NF-κB and STAT3 signalling

Journal of functional foods, 2015-05, Vol.15, p.274-283

2015

Volltextzugriff (PDF)

Cancer-treatment-induced bone loss, part 1

American journal of health-system pharmacy, 2006-03, Vol.63 (5), p.419-430

2006

Volltextzugriff (PDF)

Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib

Oncology reports, 2014-02, Vol.31 (2), p.835-841

2014

Volltextzugriff (PDF)

Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate Cancer

The New England journal of medicine, 1998-09, Vol.339 (12), p.785-791

1998

Volltextzugriff (PDF)

Cancer-treatment-induced bone loss, part 2

American journal of health-system pharmacy, 2006-03, Vol.63 (6), p.534-546

2006

Volltextzugriff (PDF)

Phase I Trial of Weekly Docetaxel With Concurrent Three-Dimensional Conformal Radiation Therapy in the Treatment of Unfavorable Localized Adenocarcinoma of the Prostate

Journal of clinical oncology, 2004-05, Vol.22 (10), p.1909-1915

2004

Volltextzugriff (PDF)

Selecting an anticoagulant for recurrent venous thromboembolism in cancer

American journal of health-system pharmacy, 2005-11, Vol.62 (22 Supplement 5), p.S10-S13

Goodin, Susan

2005

Volltextzugriff (PDF)

Antiemetic care for patients with breast cancer: Focus on drug interactions and safety concerns

American journal of health-system pharmacy, 2007-11, Vol.64 (21), p.2227-2236

2007

Volltextzugriff (PDF)

Inhibitory Effect of a γ-Tocopherol-Rich Mixture of Tocopherols on the Formation and Growth of LNCaP Prostate Tumors in Immunodeficient Mice

Cancers, 2011-09, Vol.3 (4), p.3762-3772

2011

Volltextzugriff (PDF)

Erlotinib : Optimizing therapy with predictors of response?

Clinical cancer research, 2006-05, Vol.12 (10), p.2961-2963

GOODIN, Susan

2006

Volltextzugriff (PDF)

Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies

The Prostate, 2010-09, Vol.70 (13), p.1388-1394

2010

Volltextzugriff (PDF)

1 – 25 von 134

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(124)

Publikationsform

Sprache

Englisch
(134)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lapatinib: A dual inhibitor of human epidermal growth factor receptor tyrosine kinases

Novel cytotoxic agents: Epothilones

Mechanistic Study of Inhibitory Effects of Metformin and Atorvastatin in Combination on Prostate Cancer Cells in Vitro and in Vivo

Combination of α-Tomatine and Curcumin Inhibits Growth and Induces Apoptosis in Human Prostate Cancer Cells

Epothilones: Mechanism of Action and Biologic Activity

Oral chemotherapeutic agents: Understanding mechanisms of action and drug interactions

Development of monoclonal antibodies for the treatment of colorectal cancer

Inhibitory effect of roburic acid in combination with docetaxel on human prostate cancer cells

Eriocitrin in combination with resveratrol ameliorates LPS-induced inflammation in RAW264.7 cells and relieves TPA-induced mouse ear edema

Combination of diethyldithiocarbamate with 12-O-tetradecanoyl phorbol-13-acetate inhibits the growth of human myeloid leukemia HL-60 cells in vitro and in xenograft model

Pharmacists’ critical role in cancer clinical trials

Synergistic inhibitory effect of α-humulene and sclareol on human pancreatic cancer cells

Essential Oils from Zingiber striolatum Diels Attenuate Inflammatory Response and Oxidative Stress through Regulation of MAPK and NF-κB Signaling Pathways

Pharmacokinetics of Cetuximab After Administration of Escalating Single Dosing and Weekly Fixed Dosing in Patients with Solid Tumors

Potent inhibitory effect of terpenoids from Acanthopanax trifoliatus on growth of PC-3 prostate cancer cells in vitro and in vivo is associated with suppression of NF-κB and STAT3 signalling

Cancer-treatment-induced bone loss, part 1

Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib

Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate Cancer

Cancer-treatment-induced bone loss, part 2

Phase I Trial of Weekly Docetaxel With Concurrent Three-Dimensional Conformal Radiation Therapy in the Treatment of Unfavorable Localized Adenocarcinoma of the Prostate

Selecting an anticoagulant for recurrent venous thromboembolism in cancer

Antiemetic care for patients with breast cancer: Focus on drug interactions and safety concerns

Inhibitory Effect of a γ-Tocopherol-Rich Mixture of Tocopherols on the Formation and Growth of LNCaP Prostate Tumors in Immunodeficient Mice

Erlotinib : Optimizing therapy with predictors of response?

Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies

Suchergebnisse filtern